Literature DB >> 19006510

Chemoprophylaxis compliance in a French battalion after returning from malaria-endemic area.

Lénaïck Ollivier1, Rémy Michel, Marie-Paule Carlotti, Pierre Mahé, Olivier Romand, Alain Todesco, René Migliani, Jean-Paul Boutin.   

Abstract

Incidence of malaria is increasing in travelers and soldiers. In 2006, a survey was performed in a French battalion returning from a malaria-endemic area. According to the chemoprophylaxis plasma concentration and the individuals' reports, the noncompliance rates were high, respectively, 63.4 and 54.7%.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19006510     DOI： 10.1111/j.1708-8305.2008.00219.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


  11 in total

1.  Pharmaceutical care model to assess the medication-related risks of travel.

Authors:  Ian M Heslop; Michelle Bellingan; Richard Speare; Beverley D Glass
Journal:  Int J Clin Pharm       Date:  2014-10-01

2.  Compliance with antimalarial chemoprophylaxis in German soldiers: a 6-year survey.

Authors:  H Frickmann; N G Schwarz; H-U Holtherm; W Maassen; F Vorderwülbecke; K Erkens; M Fischer; T Morwinsky; R M Hagen
Journal:  Infection       Date:  2013-01-31       Impact factor: 3.553

3.  Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa.

Authors:  Noémie Resseguier; Vanessa Machault; Lénaick Ollivier; Eve Orlandi-Pradines; Gaetan Texier; Bruno Pradines; Jean Gaudart; Alain Buguet; Catherine Tourette-Turgis; Christophe Rogier
Journal:  Malar J       Date:  2010-02-03       Impact factor: 2.979

4.  Determinants of compliance with anti-vectorial protective measures among non-immune travellers during missions to tropical Africa.

Authors:  Emmanuel Sagui; Noémie Resseguier; Vanessa Machault; Lénaïck Ollivier; Eve Orlandi-Pradines; Gaetan Texier; Frédéric Pages; Remy Michel; Bruno Pradines; Sébastien Briolant; Alain Buguet; Catherine Tourette-Turgis; Christophe Rogier
Journal:  Malar J       Date:  2011-08-10       Impact factor: 2.979

5.  Absence of correlation between ex vivo susceptibility to doxycycline and pfteQ-pfmdt gene polymorphism in French Guiana.

Authors:  Marie Mura; Sébastien Briolant; Damien Donato; Béatrice Volney; Stéphane Pelleau; Lise Musset; Eric Legrand
Journal:  Malar J       Date:  2015-07-25       Impact factor: 2.979

6.  Use of short message service (SMS) to improve malaria chemoprophylaxis compliance after returning from a malaria endemic area.

Authors:  Lénaïck Ollivier; Olivier Romand; Catherine Marimoutou; Rémy Michel; Corinne Pognant; Alain Todesco; René Migliani; Dominique Baudon; Jean-Paul Boutin
Journal:  Malar J       Date:  2009-10-23       Impact factor: 2.979

7.  Summary of recommendations for the prevention of malaria by the Committee to Advise on Tropical Medicine and Travel (CATMAT).

Authors:  A Boggild; J Brophy; P Charlebois; M Crockett; J Geduld; W Ghesquiere; P McDonald; P Plourde; P Teitelbaum; M Tepper; S Schofield; A McCarthy
Journal:  Can Commun Dis Rep       Date:  2014-04-03

8.  Environmental determinant of malaria cases among travellers.

Authors:  Gaëtan Texier; Vanessa Machault; Meili Barragti; Jean-Paul Boutin; Christophe Rogier
Journal:  Malar J       Date:  2013-03-04       Impact factor: 2.979

9.  Malaria in tunisian military personnel after returning from external operation.

Authors:  Faïda Ajili; Riadh Battikh; Janet Laabidi; Rim Abid; Najeh Bousetta; Bouthaina Jemli; Nadia Ben Abdelhafidh; Louzir Bassem; Saadia Gargouri; Salah Othmani
Journal:  Malar Res Treat       Date:  2013-05-23

10.  Epidemiological and entomological studies of a malaria outbreak among French armed forces deployed at illegal gold mining sites reveal new aspects of the disease's transmission in French Guiana.

Authors:  Vincent Pommier de Santi; Romain Girod; Marie Mura; Aissata Dia; Sébastien Briolant; Félix Djossou; Isabelle Dusfour; Alexandre Mendibil; Fabrice Simon; Xavier Deparis; Frédéric Pagès
Journal:  Malar J       Date:  2016-01-22       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.